Tardive dyskinesia (TD) is a movement disorder that can develop with the use of dopamine
receptor-blocking agents and is most commonly caused by antipsychotics. The use of …

Background Although clozapine is effective for treatment-resistant schizophrenia (TRS), the
rate of clozapine prescription is still low. Whereas antipsychotic monotherapy is …

Aim This study aims to examine the real‐world effectiveness of education regarding clinical
guidelines for psychiatric disorders using 'the Effectiveness of guidelines for dissemination …

Study objectives To investigate the proportion of inpatients with schizophrenia and major
depressive disorder prescribed hypnotic medication, and the association between such …

Background The decision to initiate clozapine treatment should be made on an individual
basis and may be closely related to the early detection of treatment‐resistant schizophrenia …

Risperidone is commonly used to treat different psychiatric disorders worldwide. Knowledge
on dose–concentration relationships of risperidone treatment in children and adolescents …

Background Clinical practice guidelines for schizophrenia and major depressive disorder
have been published. However, these have not had sufficient penetration in clinical settings …

Background Although several guidelines indicate that daily pharmacotherapy is an
important part of the treatment of schizophrenia and major depressive disorder, there are …

The family as one of system support for schizophrenia treatment in the primary care setting
has been a challenge in integrating family services into mental health. This study aimed to …

In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not
recommended. We investigated the characteristics of the use of anticholinergics in patients …